Within the EU’s 7th Framework programme, a grant of EUR 6 million has been awarded to the UNISEC Consortium, a joint effort to develop a new universal influenza vaccine involving three university partners, five national health institutes and four small and medium-sized enterprises. In this context, UNISEC partners Prof. E. Hak (Pharmacoepidemiology and Pharmacoeconomics) and Prof. E. Frijlink (Pharmaceutical Technology and Biopharmacy) of the Groningen Research Institute of Pharmacy will receive EUR 1.5 million; Prof. A. Huckriede (Molecular Virology) of the UMCG will receive EUR 0.5 million.
Combining leading expertise in influenza vaccine research and development with a proven track record, including participation in the successful EU FLUSECURE project, the UNISEC partners aim to develop a vaccine that offers both universal protection and commercial opportunity. In a single study, the three most promising vaccines are identified, further developed and clinically tested. The results will directly contribute to the development of a timely, longer-term, broader, more effective and cheaper universal vaccine for the prevention of annual and pandemic influenza.
The Dutch Research Council (NWO) has awarded Vici grants, worth up to €1.5 million each, to Nathalie Katsonis, Edwin Otten and Alexandra Zhernakova. Professor of Coastal Ecology Tjisse van der Heide has also received a Vici grant for research he...
One moment he contributes to the development of a scientific instrument for a megatelescope, the next he is working on generating energy from the ocean: Bayu Jayawardhana moves effortlessly through the world of mechatronics and nonlinear control...
Prof. Marleen Kamperman has been appointed as a new scientific member of The Royal Holland Society of Sciences (KHMW)
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether you want to accept
or reject other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information